Preprint
Analogues of the anti-malaria drug mefloquine have broad spectrum antifungal activity and are efficacious in a model of disseminated Candida auris infection
bioRxiv
Cold Spring Harbor Laboratory
08/30/2024
DOI: 10.1101/2024.08.29.610379
PMCID: PMC11383691
PMID: 39257751
Abstract
Only three classes of antifungal drugs are currently in clinical use. Here, we report that derivatives of the malarial drug mefloquine have broad spectrum antifungal activity including difficult to treat molds and endemic fungi. Pharmacokinetic and efficacy studies of NSC-4377 indicate it penetrates the central nervous system and is active against
Candida auris
in vivo. These data strongly support the further development of mefloquine analogs as a potentially new class of antifungal molecules.
Details
- Title: Subtitle
- Analogues of the anti-malaria drug mefloquine have broad spectrum antifungal activity and are efficacious in a model of disseminated Candida auris infection
- Creators
- Soumitra Guin - Saint Louis UniversityMarhiah C. Montoya - Duke UniversityXiaoyu Wang - The University of Texas Southwestern Medical CenterRobert Zarnowski - University of Wisconsin–MadisonDavid R. Andes - University of Wisconsin–MadisonMarvin J. Meyers - Saint Louis UniversityNoelle S. Williams - The University of Texas Southwestern Medical CenterDamian J. Krysan - University of Iowa
- Resource Type
- Preprint
- Publication Details
- bioRxiv
- DOI
- 10.1101/2024.08.29.610379
- PMID
- 39257751
- PMCID
- PMC11383691
- NLM abbreviation
- bioRxiv
- eISSN
- 2692-8205
- Publisher
- Cold Spring Harbor Laboratory
- Language
- English
- Date posted
- 08/30/2024
- Academic Unit
- Molecular Physiology and Biophysics; Stead Family Department of Pediatrics; Infectious Disease (Pediatrics)
- Record Identifier
- 9984702847402771
Metrics
16 Record Views